DGCR8 and ovarian cancer: Knockdown of DGCR8 in ovarian cancer cells disturbs their proliferation, migration, and invasion and increases their sensitivity to the chemotherapeutic drug cisplatin (93), which suggests that an elevated level of DGCR8 is associated with carcinogenesis.